Antiparkinson potential of -opioid receptor agonists

By Hudzik T.J.   Howell A.   Payza K.   Cross A.J.  

European Journal of Pharmacology, Vol. 396, Iss. 2, 2000-05 ,pp. : 101-107

Elsevier

Access to resources Recommend Favorite

Characterization of the -opioid receptor found in SH-SY5Y neuroblastoma cells

By Toll L.   Polgar W.E.   Auh J.S.  

European Journal of Pharmacology, Vol. 323, Iss. 2, 1997-04 ,pp. : 261-267

Elsevier

Access to resources Recommend Favorite

Relative efficacies of -opioid receptor agonists at the cloned human -opioid receptor

By Quock R.M.   Hosohata Y.   Knapp R.J.   Burkey T.H.   Hosohata K.   Zhang X.   Rice K.C.   Nagase H.   Hruby V.J.   Porreca F.   Roeske W.R.   Yamamura H.I.  

European Journal of Pharmacology, Vol. 326, Iss. 1, 1997-05 ,pp. : 101-104

Elsevier

Access to resources Recommend Favorite

Differential antagonism of the rate-decreasing effects of -opioid receptor agonists by naltrexone and norbinaltorphimine

By Powell K.R.   Holtzman S.G.  

European Journal of Pharmacology, Vol. 377, Iss. 1, 1999-07 ,pp. : 21-28

Elsevier

Access to resources Recommend Favorite

Effects of -opioid receptor agonists on long-term cocaine use and dopamine neurotransmission

By Collins S.L.   D'Addario C.   Izenwasser S.  

European Journal of Pharmacology, Vol. 426, Iss. 1, 2001-08 ,pp. : 25-34

Elsevier

Access to resources Recommend Favorite